Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity

Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has resulted in the death of more than 328,000 persons worldwide in the first 5 months of 2020. Herculean efforts to rapidly design and produce vaccines and other antiviral intervent...

Full description

Bibliographic Details
Main Authors: Stephen L. Sturley, Tamayanthi Rajakumar, Natalie Hammond, Katsumi Higaki, Zsuzsa Márka, Szabolcs Márka, Andrew B. Munkacsi
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:Journal of Lipid Research
Subjects:
severe acute respiratory syndrome coronavirus 2
cholesterol
cholesterol trafficking
lysosomal storage disease
Niemann-Pick disease
dyslipidemias
Online Access:http://www.sciencedirect.com/science/article/pii/S002222752043576X

Internet

http://www.sciencedirect.com/science/article/pii/S002222752043576X

Similar Items